Showing results (121-130 of 1,279) with videos related to
Sort By:
Pageof 128
Handbook of Experimental Pharmacology|October 5, 2013
Endothelin receptor antagonistsMartine Clozel, Alessandro Maresta, Marc HumbertExpert Opinion on Therapeutic Targets|December 22, 2016
Restoring BMPRII functions in pulmonary arterial hypertension: opportunities, challenges and limitationsChristophe Guignabert, Sabine Bailly, Marc HumbertClinics in Chest Medicine|August 30, 2012
Immunologic therapeutic interventions in asthma: impact on natural historyArnaud Bourdin, Marc Humbert, Pascal ChanezSeminars in Respiratory and Critical Care Medicine|August 27, 2005
Current insights on the pathogenesis of pulmonary arterial hypertensionFrédéric Perros, Peter Dorfmüller, Marc HumbertCurrent Opinion in Pulmonary Medicine|April 9, 2010
Endpoints in pulmonary arterial hypertension: the role of clinical worseningAndrew Peacock, Anne Keogh, Marc HumbertCurrent Opinion in Pulmonary Medicine|November 2, 2016
Novel targets of omalizumab in asthmaCaroline Sattler, Gilles Garcia, Marc HumbertThe European Respiratory Journal|August 5, 2020
Sleep-related breathing disorders and pulmonary hypertensionYochai Adir, Marc Humbert, Ari ChaouatArthritis and Rheumatism|May 4, 2011
Systemic sclerosis-related pulmonary hypertension associated with interstitial lung disease: impact of pulmonary arterial hypertension therapiesJérôme Le Pavec, Reda E Girgis, Noah Lechtzin, et al.Progress in Cardiovascular Diseases|November 2, 2002
Primary pulmonary hypertension: Current therapyOlivier Sitbon, Marc Humbert, Gérald SimonneauThe Journal of Allergy and Clinical Immunology|June 18, 2021
COVID-19 risk and outcomes in adult asthmatic patients treated with biologics or systemic corticosteroids: Nationwide real-world evidenceYochai Adir, Marc Humbert, Walid SalibaPageof 128